OpenAI‘s product and business chief Fidji Simo announced several leadership changes on Friday, after disclosing that she is taking medical leave due to a worsening neuroimmune condition called Postural Orthostatic Tachycardia Syndrome (POTS).
POTS Relapse Sidelines Product Chief
Simo, who joined OpenAI in May after serving as Instacart (NASDAQ:CART) CEO and spending more than a decade at Meta (NASDAQ:META), informed her staffers in a memo that she had been postponing medical tests and new therapies to remain focused on her job, according to a memo. However, she now needs to take time off to stabilize her health.
During an interview with CNBC in March, Simo revealed that she was diagnosed with POTS in 2019. The condition is a chronic disorder of the autonomic nervous system that makes it difficult for patients to maintain stable blood pressure, causing symptoms such as dizziness, fatigue and chest pain.
This post was originally published here
